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Objective: Laparoscopic surgery is the gold standard for benign ovarian tumors because of its overall
improved quality of life (QOL). However, some tumors diagnosed preoperatively as benign may be
proven to be malignant by postoperative studies. The standard approach for the removal of a malignant
ovarian tumor in our hospital is via laparotomy; however, there is no referential prognostic data on
malignancies that are excised laparoscopically. To evaluate clinical and histological factors and prognosis,
this study retrospectively reviewed patients who underwent surgery in our hospital, based on a pre-
operative diagnosis of benignancy, but later postoperative testing proved their tumors to be borderline or
malignant.
Participants and methods: The study group comprised 1322 women who underwent a laparoscopic
procedure in our hospital on the basis of a preoperative diagnosis of a benign ovarian tumor. The pro-
cedures were performed between 1995 and 2011. The rate of borderline and malignant cases, histology,
and postoperative treatment were investigated.
Results: Of the 1322 patients, 15 (1.1%) patients were postoperatively diagnosed as having a borderline
malignancy with various histological types and all of these patients had a good prognosis; four (0.3%)
patients were postoperatively diagnosed as having a malignant tumor with various histological types; of
these patients, two patients required emergency surgery. All four patients underwent additional surgery
and chemotherapy with no recurrence to date.
Conclusion: Some tumors diagnosed preoperatively as benign proved postoperatively to be malignant.
Appropriate postoperative treatment effectively improved the prognosis. Particular attention should be
paid to a possible occult malignancy that may manifest postoperatively, especially in patients who un-
derwent emergency surgery. We recommend preoperative magnetic resonance imaging, even for
emergency cases, to improve preoperative diagnosis.
Copyright  2013, The Asia-Paciﬁc Association for Gynecologic Endoscopy and Minimally Invasive
Therapy. Published by Elsevier Taiwan LLC. All rights reserved.Introduction
An ovarian tumor is a very common gynecological tumor.
Laparoscopic surgery is the gold standard for benign ovarian tu-
mors because of its overall improved quality of life (QOL).1 It has
been reported in Japan that 70.1% of ovarian tumors preoperatively
diagnosed as benign are laparoscopically excised.2 However, 0.4 %
of tumors diagnosed preoperatively as benign are proven post-
operatively to be malignant. In these patients, intraoperative cystand Gynecology, Kinki Uni-
ka-Sayama, Osaka 589-8511,
Y. Kotani).
ia-PaciﬁcAssociationforGynecologicErupture can be a great risk with laparoscopic surgery. Intra-
operative cyst rupture may cause upstaging, and some patients
require additional treatment or chemotherapy postoperatively.
Laparoscopic surgery is more likely to cause cyst rupture than open
surgery.3 These malignant cases essentially undergo a standard
laparotomy; however, at present there is no referential data
regarding either the prognosis or the consensus to indicate lapa-
roscopy unconditionally for early-stage ovarian cancer.
This study retrospectively reviewed ovarian cancer cases
involving women in our hospital who underwent surgery based on
a preoperative diagnosis of a benign tumor that postoperatively
proved to be borderline malignant or malignant. By investigating
these cases, we attempted to obtain concrete prognostic data and
clinical and histological ﬁndings.ndoscopyandMinimally InvasiveTherapy.PublishedbyElsevierTaiwanLLC.All rightsreserved.
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The study group comprised 1322 women who underwent a
laparoscopic procedure in our hospital for an ovarian tumor
that was preoperatively diagnosed as benign. The procedures
took place between January 1995 and December 2011 and
involved 1089 cases of ovarian tumorectomy and 233 cases of
adnexectomy.
Among these cases, the rate of borderline malignant and ma-
lignant cases was based on postoperative pathology. The following
data were furthermore reviewed: patient age, tumor size, surgical
procedure, histological type, incidence of cyst rupture, and post-
operative treatment. Based on the postoperative pathologic diag-
nosis, the patients were classiﬁed in three groups: “benign”,
“borderline malignant”, and “malignant”. The preoperative mean
patient age and mean largest tumor diameter were compared
among the groups.
The preoperative diagnosis in our institution was based on ul-
trasonography, computed tomography (CT), and magnetic reso-
nance imaging (MRI). The solid portion of the tumor and the wall
thickness were evaluated to differentiate between benignancy and
malignancy.4 (However, some emergent cases underwent surgery
after CT and/or ultrasound examination only.) Based on the pre-
operative diagnosis, we selected laparoscopy for benignancy and
open surgery for malignancy and tumors for which malignancy
could not be ruled out.
In our department, laparoscopy is performed by ﬁrst attaining
pneumoperitoneum through the umbilicus by using a closed
method. Three 5-mm trocars are inserted at the following loca-
tions: the umbilicus, the midline of the lower abdomen, and the
right side of the lower abdomen. One 12-mm trocar is inserted in
the left lower abdomen. Adnexectomy is performed by doubly
ligating the suspensory ovarian ligament, followed by the coagu-
lation and dissection of the fallopian tube and ovarian ligament; the
adnexa is then excised. Ovarian tumorectomy is performed by
making an incision halfway around the tumor along the equatorial
line, starting from the opposite side of the ovarian hilum. The tu-
mor is then carefully dissected to avoid cyst rupture. After aspi-
rating the contents into the pouch of an Endo Catch Gold (Ethicon,
Tokyo, Japan), which is inserted through the 12 mm trocar. The
tumor is then transferred out of the abdomen.
For statistical analysis, the Mann-Whitney t test was used to
compare themean values between the two groups. A p value< 0.05
was considered statistically signiﬁcant.Table 1
Patient age, tumor size, procedure, result, and follow-up of the postoperative borderline
Case no. Age at surgery (years) Tumor diameter (cm) Procedure
1 30 4.5 LC
2 30 7 LC
3 47 5 LC
4 28 8 LC
5 36 4 LC
6 43 6 LC
7 30 8 LC
8 35 6 LC
9 26 8 LC
10 79 6 LA
11 51 5 LA
12 34 7 LC
13 32 8 LC
14 36 2 LC
15 38 5 LC
Mean 38.3 6.0
BM ¼ borderline malignancy; LA ¼ laparoscopic adnexectomy; LC ¼ laparoscopic cystecResults
Of the 1322 women, 15 (1.1%) women were postoperatively
diagnosed as having borderline malignancy and four (0.3%) women
were postoperatively diagnosed as having a malignancy. Table 1
summarizes the patient age, tumor size, surgical procedure, his-
tological type, incidence of cyst rupture, and postoperative treat-
ment in regard to the patients postoperatively diagnosed as
borderline malignant. The mean patient age was 38.3 years and the
mean largest tumor size was 6.0 cm. Laparoscopic adnexectomy
was performed for two menopausal women, and laparoscopic
ovarian tumorectomy was performed for the other 13 women who
were premenopausal. Cyst rupture occurred in 10 of 15 patients.
Histological types of tumors were serous cystadenoma (four pa-
tients), mucinous cystadenoma (four patients), immature teratoma
G1 (four patients), granulosa cell tumor (two patients), and endo-
metrial cyst (one patient). A subsequent adnexectomy was per-
formed in four patients. To date, recurrence has been conﬁrmed in
only one patient. This patient developed ipsilateral ovarian tumors
at 1 year and at 3 years postoperatively. She was undergoing
infertility treatment and an ovarian tumorectomy was performed
for both recurrences. The conservative procedures were performed
in accordance with her desire to preserve her fertility. She gave
informed consent. The histological type was the same for all the
three surgeries: mucinous cystadenoma, which is a borderline
malignancy. At present, 3 years after her last surgery, she has not
experienced a recurrence.
Table 2 summarizes the preoperative patient age, tumor size,
surgical procedure, histological type, incidence of cyst rupture, and
postoperative treatment in regard to patients postoperatively
diagnosed as having a malignancy. The mean patient age was 33.8
years and the mean largest tumor size was 8.5 cm (Table 3).
Laparoscopic ovarian tumorectomy was performed for all of these
patients. Cyst rupture occurred in one patient. In two of four pa-
tients, the cyst had already naturally ruptured preoperatively (i.e.,
voluntary rupture). Histological types were one case each of serous
cystadenocarcinoma, mucinous cystadenocarcinoma, yolk sac tu-
mor, and squamous cell carcinoma (i.e., malignant transformation
from a mature cystic teratoma). The serous cystadenocarcinoma
case was complicated by tumor torsion and cyst rupture. The
squamous cell carcinoma case was complicated by cyst rupture.
Both patients required emergency surgery. Therefore, in these pa-
tients, only a CT scan was performed preoperatively; MRI was
omitted to save time. The yolk sac tumor casewas ﬁrst diagnosed ascases.
Cyst rupture Histology Postoperative treatment
Present Serous cyst adenoma (BM)
Present Granulosa cell tumor LA
None Immature teratoma G1
Present Immature teratoma G1
Present Granulosa cell tumor
Present Mucinous cyst adenoma (BM) LA
Present Mucinous cyst adenoma (BM) LC at 2 recurrences
Present Endometrial cyst (BM)
None Immature teratoma G1 LA
None Serous cyst adenoma (BM)
None Mucinous cyst adenoma (BM)
Present Serous cyst adenoma (BM)
Present Mucinous cyst adenoma (BM) LA
None Immature teratoma G1
Present Serous cyst adenoma (BM)
tomy.
Table 2
Patient age, tumor size, procedure, result, and follow-up of the postoperative malignancy cases.
Case no. Age at surgery (years) Tumor diameter (cm) Procedure Cyst rupture Histology Postoperative treatmenta
1 36 8 LC Voluntary Serous cyst adenocarcinoma Standard surgery for ovarian cancer*/TC
2 19 10 LC None Yolk sac tumor Adnexectomy/biopsy of the healthy
side/omentectomy/BEP
3 42 9 LC Present Mucinous cyst adenocarcinoma Standard surgery for ovarian cancer/TC
4 38 7 LC Voluntary Squamous cell carcinoma Standard surgery for ovarian cancer/TC
Mean 33.8 8.5
LC ¼ laparoscopic cystectomy; TC ¼ paclitaxel and carboplatin; BEP ¼ bleomycin, etoposide, and cisplatin.
a Standard surgery for ovarian cancer include abdominal total hysterectomy, bilateral adnexectomy, retroperitoneal lymph node dissection, and omentectomy.
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tumor by MRI; however, the ﬁnal diagnosis was a yolk sac tumor.
All patients underwent additional surgery and chemotherapy with
no recurrence to date.
On the basis of the postoperative pathology, the patients were
classiﬁed into three groups: benign, borderline malignancy, and
malignancy. The mean patient age and mean largest tumor diam-
eter were compared among the groups. No signiﬁcant difference
was found in the mean preoperative age between benignancy (36.5
years, based on 1303 patients), borderline malignancy (38.3 years,
15 patients), and malignancy (33.8 years, four patients). A signiﬁ-
cant difference was conﬁrmed in the mean largest tumor diameter
between the malignant tumors and the other two groups: malig-
nant, 8.5 cm; benign, 6.2 cm; and borderline, 6.0 cm.
Discussion
Various factors should be considered when laparoscopic sur-
gery is performed for a preoperatively diagnosed benign ovarian
tumor, which postoperatively proves to be malignant or border-
line: (1) upstaging by intraoperative cyst rupture; (2) challenge in
obtaining accurate staging because of an insufﬁcient sample
collected; (3) possible delay in primary treatment; (4) metastases
or recurrence at the trocar insertion site; and (5) growth or
development of tumor cells triggered by pneumonia. Canis et al5
stated that intraoperative cyst rupture is an important prog-
nostic factor for stage I ovarian cancer. Furthermore, the laparo-
scopic puncture of malignant ovarian tumors conﬁned to the
ovaries is uncommon and should be avoided whenever possible.5
Vergote et al6 report that cyst rupture prior to or during surgery
decreases disease-free survival and should be avoided in patients
with a possible diagnosis of ovarian carcinoma that is conﬁned to
the ovaries. However, Ahmed et al7 report that intraoperative
rupture is not a prognostic factor. The possible negative impact of
intraoperative cyst rupture on the prognosis of early-stage ovarian
cancer is controversial.8
In regard to borderline malignancy, the 10-year survival rate for
stage I is 97%, which indicates a better prognosis in comparison to
malignant cases. Some investigators have reported that the prog-
nosis was the same in Stage IC even if the standard open surgery forTable 3
Mean patient age and mean largest tumor diameter by group.
Benignancy
n ¼ 1303
Borderline
n ¼ 15
Malignancy
n ¼ 4
Age (years) (range) 36.5  12.9
(7e93)
38.3  13.3
(26e79)
33.8  10.1
(19e42)
Tumor diameter
(cm) (range)
6.2  2.6
(1e20)
6.0  1.8
(2e8)
8.5  1.3*
(7e10)
Data are presented as mean  standard deviation and range.
* In the largest mean tumor diameter, a signiﬁcant difference was conﬁrmed be-
tween the malignant group and each of the other two groups; p < 0.05.ovarian cancer is not subsequently performed.9e11 The prognoses
for our patients were good, even without additional surgery or
chemotherapy.
In view of the foregoing, we ﬁrst differentiatedmalignancy from
benignancy by preoperative MRI. We also employed the utmost
effort to avoid intraoperative cyst rupture in all patients. However,
this study revealed that, of the preoperatively diagnosed benign
cases, 1.1% of the cases were in fact borderline and 0.3% of the cases
were malignant. Two malignant cases required emergency surgery,
which means preoperative ultrasonography and CT are insufﬁcient
in detecting the solid portion of the tumor because of the inferior
imaging quality of these techniques in comparison to MRI.4 Even a
small solid area can be malignant.4 Therefore, in emergency sur-
gery, particular attention should be paid to a possible occult ma-
lignancy that may be revealed postoperatively.
Shiota et al3 report that the rate of cyst rupture during ovarian
tumorectomy was signiﬁcantly higher in laparoscopy than in lap-
arotomy. However, cyst rupture rate during adnexectomy is com-
parable between laparoscopy and laparotomy for tumors <10 cm.
For tumors 10 cm, laparoscopy reportedly has a signiﬁcantly
higher cyst rupture rate than laparotomy.3 In our hospital, although
we try our best to avoid cyst rupture, it cannot always be circum-
vented because of individual patient characteristics. All malignant
tumors in this study were <10 cm and the mean largest diameter
was signiﬁcantly larger than the size of benign masses. Increased
risk of malignancy is reported for larger tumors, especially tumors
that are>10 cm in diameter.12 If any suspicion of malignancy exists
and laparoscopy is selected, adnexectomy should be performed
rather than tumorectomy. Laparotomy should alternatively be
selected to minimize potential cyst rupture.
In conclusion, this study found that appropriate postoperative
treatment resulted in a favorable prognosis for postoperatively
diagnosed borderline and malignant tumors in our hospital. Of
most importance is the accurate preoperative differentiation be-
tween benignancy and malignancy. However, in emergency cases
in which the most reliable modality cannot be used for evaluation
because of time constraints, it is important to consider the possi-
bility of an occult malignancy and employ meticulous technique
during surgery to reduce the risk of cyst rupture.References
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